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A B S T R A C T
Medication withdrawal (MW) is an important method of provoking seizures and activating epileptiform
EEG activity during the diagnostic work-up of patients evaluated for epilepsy surgery. Previously it was
suggested that MWmight inﬂuence the seizure-type and activate cortical areas otherwise not producing
epileptiform discharges, leading to a false localization of the irritative zone. In order to investigate this
we reviewed 42 consecutive cases of MW, of 36 patients, during a 3-year period. We compared seizure
frequency, seizure-types and the localization of interictal epileptiform discharges before and after MW.
Seizure frequency was signiﬁcantly higher after MW. In the whole group we found an increase in seizure
propagation: the proportion of the complex partial seizures and secondarily generalised seizures
increased, while the proportion of the simple partial seizures decreased following MW. In one-third of
the patients the interictal EEGs after the MW were different from those recorded before the MW.
However, in these discordant cases the EEG ﬁndings after the MW (and not before the MW) were
concordant with the seizure onset zone and the lesional zone. We conclude that MW is an effective and
reliable seizure provoking method, and it does not lead to false localization of the irritative zone.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The localization of the seizure onset zone (ictal EEG) and the
irritative zone (interictal epileptiform EEG discharges) is a key
element in the lateralization and localization of the epileptogenic
zone in the presurgical evaluation of patients considered for
epilepsy surgery.1 The clinical aim and advantage of the medica-
tion withdrawal (MW) is to activate the interictal activity and to
provoke seizures in order to reduce the duration of the long-term
EEG monitoring (LTM).2
The possibility that MW activates cortical areas otherwise not
producing epileptiform discharges and/or seizures has been
raised.1,3–6 This would lead to an erroneous localization of the
epileptogenic zone.1 However several studies demonstrated that
MW does not induce signiﬁcant changes in the localization of the
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doi:10.1016/j.seizure.2010.01.001The effect of MW on the localization of interictal epileptiform
activity received surprisingly little attention. Ludwig and Marsan3
found a ‘‘nonspeciﬁc’’ activation of generalised epileptiform
discharges in 63% of their cases. To gain further knowledge on
this, we analysed data from our patients who had MW during the
presurgical evaluation.
2. Methods
We retrospectively reviewed 42 consecutive cases of MW
during a 3-year period (2006–2008) of 36 patients (26 female, 10
male), aged between 16 and 67 years (mean: 39 years). Four
patients had 2 cases of MW and 1 patient had 3MWs, separated by
more than 6 months. All patients had localization-related epilepsy
(31 had temporal, and 5 had extratemporal foci) and they were
evaluated for epilepsy surgery.
The procedure of MW was individualised and determined by
the patient-speciﬁc parameters, in accordance with suggested
guidelines.2 Medication was typically withdrawn to 30–50% of the
prescribed daily doses of antiepileptic drugs (AED)within 3–7 days
before EEG monitoring in most of the cases.
In 7 cases patients were on monotherapy, in 23 cases on
bitherapy and in 12 cases the patients were on 3 or more AED. MW
was planned for each patient individually based on their treatmentvier Ltd. All rights reserved.
Table 2
Localization of the interictal epileptiform discharges (before and after MW), seizure
onset zone and lesional zone for the 12 patients with discordant data; l, left; r, right;
bi, bilateral, synchronous; T, temporal; F, frontal; none: abnormalities in none of the
regions (i.e. ‘‘normal’’ result).
Patient Localization of the
epileptiform discharges
Seizure
onset zone
Neuroimaging
Before MW After MW
1 l-T; l-F r-T r-T r-T
2 None l-T l-T l-T
3 l-T r-T r-T r-T
4 None l-T; r-T r-T r-T
5 l-T r-T r-T r-T
6 l-T r-T Generalised None
7 l-T l-T; r-T None r-T
8 r-T Multifocal Multifocal Multifocal
9 l-T r-T r-T r-T
10 None l-T None l-T
11 None r-T; l-T l-T l-T
12 l-T r-T r-T r-T
Table 1
Mean values for the individualised proportions of the seizure-types before and after
medication withdrawal.
Seizure-type Proportion (mean) p
Before MW After MW
Simple partial seizures 0.14 0.16 0.35
Complex partial seizures 0.81 0.65 0.07
Partial seizures evolving to secondarily
generalisation
0.05 0.17 0.06
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generalised seizures.
Seizure frequency (number of seizures/day)was determined for
the period before and after the MW for the 42 cases of MW. To
assess whether the possible changes in seizure frequency are
biased by the patients who underwent several MW-sessions, we
calculated for these patients the seizure frequency before and after
MW from all the MW cases of these patients. This allowed
comparison of the changes in seizure frequency for the 36 patients.
Before MW the patients were admitted to our epilepsy centre,
where they were continuously monitored by trained personnel for
5 days, and the seizures were recorded on video. On day 6 the
patients were admitted to our epilepsy monitoring unit (EMU).
After the registration (2–5 days) the patients were further
observed in the epilepsy centre.
Seizures were classiﬁed as simple partial, complex partial and
secondarily generalised seizures.11 To compensate for the possible
bias caused by a large increase or decrease in a seizure-type
coming from a few patients, we calculated for each patient who
had seizures during the observation period both before and after
the withdrawal, the proportion of each seizure-type (number of
the seizure-type/total number of seizures) separately for period
before and after theMW. This individualised proportion of seizure-
types compensates for the bias caused by the different seizure
frequency in different patients.
Standard EEGs (at least 30-min duration) recorded before the
MW included hyperventilation and intermittent photic stimula-
tion. When this did not result in a reliable localization of the
epileptiform discharges, repeated EEGs were recorded (up to 4
times) including sleep-EEGs following sleep-deprivation. After the
MW long-term video-EEG recordings (LTM)were performed (up to
5 days). EEGs were evaluated by 2 board-certiﬁed clinical
neurophysiologists (SB and JA). For the patients with discordant
interictal EEG ﬁndings before and after the MW we compared the
localization of the irritative zone with the localization of the
seizure onset zone and with the results of neuroimaging (MRI,
SPECT, PET).
We compared the frequency of seizures and the individualised
proportions of seizure-types before and after the MW using t-test
for paired data. The incidence of different seizure-types in the
whole group of patients before and after MW was compared by
Fisher’s exact test (two-tailed). Comparison of the concordance
between the localization of the epileptiform discharges and the
ictal onset zone, and the neuroimaging data before and after MW
was made by Fisher’s exact test (two-tailed).
3. Results
3.1. Seizure frequency
For the 42 cases of MW we found a signiﬁcant increase in the
seizure frequency during the period after withdrawal
(mean = 2.65 seizure/day) as compared with the period immedi-
ately preceding the withdrawal (mean = 0.28 seizures/day)
(p < 0.001). When comparing the seizure-frequencies of the 36
patients (calculating it from all the MW cases for those patients
who had several sessions), the results were almost identical (0.27
vs. 3.03; p < 0.001).
In 23 cases therewas not any seizure recorded during the 5 days
preceding the withdrawal. Out of these in 20 cases there was at
least 1 seizure recorded after the withdrawal, and 3 patients did
have seizure neither before, nor after withdrawal. Only 1 patient
who had seizure before withdrawal failed to produce any seizure
after withdrawal. Except for this case and the 3 cases with seizures
neither before nor afterwithdrawal, in all the other cases therewas
an increase in the seizure frequency.3.2. Seizure-types
In the whole group of patients, following MW we recorded an
increase in the proportion of the complex partial seizures (from 31
seizures = 53% to 198 seizures = 70%) and secondarily generalised
seizures (from 3 seizures = 5% to 34 seizures = 12%), while the
proportion of the simple partial seizures decreased from 42% (25
seizures) to 18% (50 seizures) (p < 0.01).
In 18 caseswe recorded seizures during the observation periods
both before and after the withdrawal. The mean values for the
individualised proportions of the seizure-types (number of the
seizure-type/number of total seizures for each patient) are shown
in Table 1. None of these changes reached the level of signiﬁcance,
although there was a trend for the increase in the individualised
proportions of secondarily generalised seizures.
3.3. Side-effects/complications
There were 2 cases of NCSE (2 different patients) in the period
following the withdrawal. Both could be easily managed with AED
and none of them led to the interruption of the LTM.
3.4. EEG before and after the MW
In one-third (12) of the 36 patients the EEG before MW was
different from the EEG recorded afterMW (Table 2). Out of these 12
patients, the result of the interictal EEG before the MW was
concordant with the seizure onset zone in only 1 patient (number
10 in Table 2). None of these 12 patients had concordant data
between the interictal EEG before the MW and the neuroimaging
data. In 7 of the 12 discordant patients the localization of the
epileptiform discharges after MWwas concordant with the seizure
onset zone, and in 8 patients it was concordant with the
neuroimaging data. The interictal EEG recorded after MW
correlated better than the EEG recorded before MW, with the
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(p = 0.001). In 4 of the 12 discordant patients the EEG recorded
before MW was normal. If we excluded these, and we only
analysed the 8 patients where the localization of the irritative zone
was different before and after MW, we obtained similar results
(p = 0.02 and 0.007 respectively).
4. Discussion
MWwas proved to be an effectivemethod of provoking seizures
and epileptiform EEG activity, during the presurgical work-up of
patients with focal epilepsy. In accordance with previous studies,
we found a signiﬁcant increase in seizure frequency following
MW.2
In the whole group there was a signiﬁcant increase in seizure
propagation (complex partial seizures and secondarily generalised
seizures) as opposed to the decrease in simple partial seizures. This
is in agreement with previously published data.6,10,12 However,
when we compared the individualised proportions of seizure-
types, the difference failed to reach the level of signiﬁcance. This
suggests that the increase in the complex partial and secondarily
generalised seizures in the whole group of patients originates from
a marked increase in a few patients.
Previously it had been suggested that MW activates cortical
areas otherwise not producing epileptiform discharges and/or
seizures leading to false localization of the epileptogenic zone.1,3–6
The only study addressing the changes in the localization of the
interictal epileptiform discharges following MW showed a
‘‘nonspeciﬁc’’ activation of generalised epileptiform discharges
in 63% of their cases.3 We found a difference in the localization of
the interictal EEG discharges before and after MW in one-third of
our patients. When calculating this, we also counted as discordant
those cases where the EEG after the MW showed a clear-cut and
localized interictal focus, but the EEG before MW was normal (i.e.
the interictal discharges were scored as localized to ‘‘none’’ of the
regions). If we excluded the patients where the EEG before theMW
was normal, we only found discordant localizations before and
after MW in 22% of the patients (8 out of 36).
For the 12 discordant patients we attempted to elucidate in
which condition (on-medication or followingMW) the localization
of the interictal epileptiform discharges is more reliable. Therefore
we compared the localization of them with the seizure onset zone
and the lesional zone. The localization of the interictal epileptiform
discharges afterMW showed a signiﬁcantly better correlationwith
the seizure onset zone and the lesional zone than those recorded
undermedication. Our results do not support the concern thatMW
might cause activation of cortical areas unrelated to the epilepto-genic zone, thus leading to false localizations. Contrary, our results
suggest that it is rather the medication that distorts the
localization of the interictal epileptiform discharges.
Our EEG data could be theoretically biased by the different
recording-times before and after MW: repeated (up to 4) standard
recordings of 30 min duration (including sleep EEG and the classic
provocation methods) vs. continuous recording (after MW).
However, we did not analyse the quantity of the epileptiform
discharges but only their localization. Up to 4 standard EEG
recordings (including sleep EEG) increase the sensitivity of the
method to up to 90%.13 On the other hand epileptiform discharges
will be found in most persons with epilepsy undergoing
monitoring during the ﬁrst hour of spontaneous sleep and if they
are not seen in this period, there is little chance of ﬁnding them by
examining a prolonged recording in its entirety.14
Our results further support that MW is a safe, effective and
reliable method for increasing the number of seizures and
activating the interictal epileptiform activity, during the pre-
surgical assessment of patients with focal epilepsy.
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